Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 128, Issue 1-2, 2006, Pages 209-215

  Harsem, Nina K ^a   Braekke, Kristin ^a   Staff, Anne Cathrine ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antioxidants; Isoprostanes; Oxidative stress; Preeclampsia

Indexed keywords

8 ISOPROSTANE; ALPHA TOCOPHEROL; ANTIOXIDANT; ISOPROSTANE DERIVATIVE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN RECEPTOR 1;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CESAREAN SECTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; OXIDATIVE STRESS; PREECLAMPSIA; PRIORITY JOURNAL; VENOUS BLOOD;

EID: 33748197733     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.11.014     Document Type: Article

References (33)

1. Roberts J.M., and Redman C.W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341 (1993) 1447-1451
2. Walsh S.W., Vaughan J.E., Wang Y., and Roberts L.J. Placental isoprostane is significantly increased in preeclampsia. FASEB J 14 (2000) 1289-1296
3. Staff A.C., Halvorsen B., Ranheim T., and Henriksen T. Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with preeclampsia. Am J Obstet Gynecol 181 (1999) 1211-1215
4. Walsh S.W. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16 (1998) 93-104
5. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
6. Hubel C.A., Roberts J.M., Taylor R.N., Musci T.J., Rogers G.M., and McLaughlin M.K. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 161 (1989) 1025-1034
7. Many A., Hubel C.A., and Roberts J.M. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 174 (1996) 288-291
8. Patrono C., and FitzGerald G.A. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17 (1997) 2309-2315
9. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., and Roberts L.J. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89 (1992) 10721-10725
10. Roberts L.J., and Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28 (2000) 505-513
11. Llurba E., Gratacos E., Martin-Gallan P., Cabero L., and Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 37 (2004) 557-570
12. Barden A., Beilin L.J., Ritchie J., Croft K.D., Walters B.N., and Michael C.A. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci 91 (1996) 711-718
13. Morris J.M., Gopaul N.K., Endresen M.J., et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 105 (1998) 1195-1199
14. Barden A., Ritchie J., Walters B., et al. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension 38 (2001) 803-808
15. Chappell L.C., Seed P.T., Briley A.L., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354 (1999) 810-816
16. Chappell L.C., Seed P.T., Kelly F.J., et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol 187 (2002) 777-784
17. Mikhail M.S., Anyaegbunam A., Garfinkel D., Palan P.R., Basu J., and Romney S.L. Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol 171 (1994) 150-157
18. Schiff E., Friedman S.A., Stampfer M., Kao L., Barrett P.H., and Sibai B.M. Dietary consumption and plasma concentrations of Vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 175 (1996) 1024-1028
19. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
20. ACOG practice bulletin, Diagnosis and management of preeclampsia and eclampsia, Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77:67-75.
21. Skjaerven R., Gjessing H.K., and Bakketeig L.S. New standards for birth weight by gestational age using family data. Am J Obstet Gynecol 183 (2000) 689-696
22. Nourooz-Zadeh J., Gopaul N.K., Barrow S., Mallet A.I., and Anggard E.E. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl 667 (1995) 199-208
23. Benzie I.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239 (1996) 70-76
24. Iamele L., Fiocchi R., and Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 40 (2002) 673-676
25. Staff A.C., Braekke K., Harsem N.K., Lyberg T., and Holthe M.R. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during preeclampsia. Eur J Obst Gyn Reprod Biol (2005) May 31
26. Svilaas A., Sakhi A.K., Andersen L.F., et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoiods in humans. J Nutr 134 (2004) 562-567
27. Astaneie F., Asfhari M., Mojtahedi A., Zamani M.J., Larijani B., and Abdollahi M. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 36 4 (2005) 376-381
28. Radfar M., Larijani B., Hadjiibabaie M., Rajabipour B., Mojtahedi A., and Abdollahi M. Effects of pentoxyfylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother 59 (2005) 302-306
29. Zusterzeel P.L., Rutten H., Roelofs H.M., Peters W.H., and Steegers E.A. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 22 (2001) 213-219
30. Cao G., and Prior R.L. Comparison of different analytic methods for assessing total antioxidant capacity of human serum. Clin Chem 44 (1998) 1309-1315
31. Halvorsen B.L., Holte K., Myhrstad M.C., et al. A systematic screening of total antioxidants in dietary plants. J Nutr 132 (2002) 461-471
32. Ghiselli A., Serafini M., Natella F., and Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29 (2000) 1106-1114
33. Staff A.C., Ranheim T., and Halvorsen B. Augmented PLA2 activity in pre-eclamptic decidual tissue-a key player in the pathophysiology of 'acute atherosis' in pre-eclampsia?. Placenta 24 (2003) 965-973